このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Jubilant Pharmova バランスシートの健全性
財務の健全性 基準チェック /36
Jubilant Pharmovaの総株主資本は₹54.2B 、総負債は₹34.1Bで、負債比率は63%となります。総資産と総負債はそれぞれ₹115.5Bと₹61.3Bです。 Jubilant Pharmovaの EBIT は₹5.2Bで、利息カバレッジ比率1.9です。現金および短期投資は₹9.6Bです。
主要情報
63.0%
負債資本比率
₹34.14b
負債
| インタレスト・カバレッジ・レシオ | 1.9x |
| 現金 | ₹9.57b |
| エクイティ | ₹54.21b |
| 負債合計 | ₹61.27b |
| 総資産 | ₹115.49b |
財務の健全性に関する最新情報
Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet
Mar 14
These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively
Dec 02These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively
Jul 26Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?
Dec 10Does Jubilant Pharmova (NSE:JUBLPHARMA) Have A Healthy Balance Sheet?
Jun 15Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?
Feb 15Recent updates
Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet
Mar 14Jubilant Pharmova Limited (NSE:JUBLPHARMA) Shares Fly 27% But Investors Aren't Buying For Growth
Dec 23These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively
Dec 02These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively
Jul 26Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)
May 11Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?
Dec 10Jubilant Pharmova (NSE:JUBLPHARMA) Has Announced A Dividend Of ₹5.00
Aug 01Does Jubilant Pharmova (NSE:JUBLPHARMA) Have A Healthy Balance Sheet?
Jun 15Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)
Mar 22Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?
Feb 15Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)
Dec 20Here's Why It's Unlikely That Jubilant Pharmova Limited's (NSE:JUBLPHARMA) CEO Will See A Pay Rise This Year
Sep 15Here's Why Jubilant Pharmova (NSE:JUBLPHARMA) Can Manage Its Debt Responsibly
Aug 21Time To Worry? Analysts Are Downgrading Their Jubilant Pharmova Limited (NSE:JUBLPHARMA) Outlook
Jun 08An Intrinsic Calculation For Jubilant Pharmova Limited (NSE:JUBLPHARMA) Suggests It's 39% Undervalued
May 25Analysts Just Made A Major Revision To Their Jubilant Pharmova Limited (NSE:JUBILANT) Revenue Forecasts
Feb 10Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBILANT)
Feb 08
Shareholders Are Thrilled That The Jubilant Life Sciences (NSE:JUBILANT) Share Price Increased 217%
Jan 11Does Jubilant Life Sciences' (NSE:JUBILANT) CEO Salary Compare Well With Industry Peers?
Dec 31Read This Before Selling Jubilant Life Sciences Limited (NSE:JUBILANT) Shares
Dec 20Has Jubilant Life Sciences Limited's (NSE:JUBILANT) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 08We Think Jubilant Life Sciences (NSE:JUBILANT) Can Stay On Top Of Its Debt
Nov 27What Kind Of Investors Own Most Of Jubilant Life Sciences Limited (NSE:JUBILANT)?
Nov 17Jubilant Life Sciences Limited Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next
Nov 06If You Like EPS Growth Then Check Out Jubilant Life Sciences (NSE:JUBILANT) Before It's Too Late
Oct 27Estimating The Fair Value Of Jubilant Life Sciences Limited (NSE:JUBILANT)
Oct 15Does Jubilant Life Sciences' (NSE:JUBILANT) Share Price Gain of 96% Match Its Business Performance?
Oct 03Trade Alert: The Independent Non-Executive Director Of Jubilant Life Sciences Limited (NSE:JUBILANT), Arun Seth, Has Just Spent ₹1.1m Buying 233% More Shares
Sep 21How Much is Jubilant Life Sciences' (NSE:JUBILANT) CEO Getting Paid?
Sep 20Jubilant Life Sciences Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Sep 08財務状況分析
短期負債: JUBLPHARMAの 短期資産 ( ₹38.8B ) が 短期負債 ( ₹18.9B ) を超えています。
長期負債: JUBLPHARMAの短期資産 ( ₹38.8B ) は 長期負債 ( ₹42.4B ) をカバーしていません。
デット・ツー・エクイティの歴史と分析
負債レベル: JUBLPHARMAの 純負債対資本比率 ( 45.3% ) は 高い と見なされます。
負債の削減: JUBLPHARMAの負債対資本比率は、過去 5 年間で100.2%から63%に減少しました。
債務返済能力: JUBLPHARMAの負債は 営業キャッシュフロー によって 十分にカバー されています ( 28.4% )。
インタレストカバレッジ: JUBLPHARMAの負債に対する 利息支払い は EBIT ( 1.9 x coverage) によって 十分にカバーされていません。